Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis
Background In patients with idiopathic pulmonary fibrosis (IPF) there is a need to identify biomarkers that 1) are associated with increased risk of adverse outcome and 2) can be used to monitor treatment response or identify disease progression over time. Methods Two consecutive cohorts of patients...
Published in: | ERJ Open Research |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2024
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85211349800&doi=10.1183%2f23120541.00570-2024&partnerID=40&md5=5288db6846ea8f9b950fb88d047d289c |
id |
2-s2.0-85211349800 |
---|---|
spelling |
2-s2.0-85211349800 George P.M.; Rennison-Jones C.; Benvenuti G.; Sifostratoudaki A.; Ottink F.A.; Bou-Zeid W.; Ledda R.E.; Abul Kadir R.F.; Johari B.; Fernandez C.; Harston G.W.J.; Joly O.; Gerry S.; Devaraj A. Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis 2024 ERJ Open Research 10 6 10.1183/23120541.00570-2024 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85211349800&doi=10.1183%2f23120541.00570-2024&partnerID=40&md5=5288db6846ea8f9b950fb88d047d289c Background In patients with idiopathic pulmonary fibrosis (IPF) there is a need to identify biomarkers that 1) are associated with increased risk of adverse outcome and 2) can be used to monitor treatment response or identify disease progression over time. Methods Two consecutive cohorts of patients with IPF were accessed from the Open Source Imaging Consortium database. Automated computed tomography (CT) biomarkers of disease severity incorporating fibrotic and pulmonary vascular features (the reticulovascular score and weighted reticulovascular score (WRVS)) were studied. Relationships between imaging biomarkers, lung function and survival were analysed. Results In separate test and validation cohorts, 168 and 176 patients with IPF respectively (median survival 2.6 years) were studied. A threshold of WRVS ⩾15% at baseline CT was most strongly associated with transplant-free survival (HR 3.00, 95% CI 1.47–6.10, p=0.002) when adjusted for baseline forced vital capacity (FVC) and age. In patients with 12-month follow-up CT and lung function tests (n=89) an increase in 3% of WRVS (the minimal clinically important difference) was also significantly associated with reduced survival independent of FVC, and outperformed visual evaluation of progressive fibrosis. Conclusions WRVS is an automated CT biomarker which can identify patients with IPF at increased risk of progression and is able to reliably capture disease progression over time. © The authors 2024. European Respiratory Society 23120541 English Article All Open Access; Gold Open Access; Green Open Access |
author |
George P.M.; Rennison-Jones C.; Benvenuti G.; Sifostratoudaki A.; Ottink F.A.; Bou-Zeid W.; Ledda R.E.; Abul Kadir R.F.; Johari B.; Fernandez C.; Harston G.W.J.; Joly O.; Gerry S.; Devaraj A. |
spellingShingle |
George P.M.; Rennison-Jones C.; Benvenuti G.; Sifostratoudaki A.; Ottink F.A.; Bou-Zeid W.; Ledda R.E.; Abul Kadir R.F.; Johari B.; Fernandez C.; Harston G.W.J.; Joly O.; Gerry S.; Devaraj A. Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis |
author_facet |
George P.M.; Rennison-Jones C.; Benvenuti G.; Sifostratoudaki A.; Ottink F.A.; Bou-Zeid W.; Ledda R.E.; Abul Kadir R.F.; Johari B.; Fernandez C.; Harston G.W.J.; Joly O.; Gerry S.; Devaraj A. |
author_sort |
George P.M.; Rennison-Jones C.; Benvenuti G.; Sifostratoudaki A.; Ottink F.A.; Bou-Zeid W.; Ledda R.E.; Abul Kadir R.F.; Johari B.; Fernandez C.; Harston G.W.J.; Joly O.; Gerry S.; Devaraj A. |
title |
Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis |
title_short |
Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis |
title_full |
Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis |
title_fullStr |
Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis |
title_full_unstemmed |
Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis |
title_sort |
Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis |
publishDate |
2024 |
container_title |
ERJ Open Research |
container_volume |
10 |
container_issue |
6 |
doi_str_mv |
10.1183/23120541.00570-2024 |
url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85211349800&doi=10.1183%2f23120541.00570-2024&partnerID=40&md5=5288db6846ea8f9b950fb88d047d289c |
description |
Background In patients with idiopathic pulmonary fibrosis (IPF) there is a need to identify biomarkers that 1) are associated with increased risk of adverse outcome and 2) can be used to monitor treatment response or identify disease progression over time. Methods Two consecutive cohorts of patients with IPF were accessed from the Open Source Imaging Consortium database. Automated computed tomography (CT) biomarkers of disease severity incorporating fibrotic and pulmonary vascular features (the reticulovascular score and weighted reticulovascular score (WRVS)) were studied. Relationships between imaging biomarkers, lung function and survival were analysed. Results In separate test and validation cohorts, 168 and 176 patients with IPF respectively (median survival 2.6 years) were studied. A threshold of WRVS ⩾15% at baseline CT was most strongly associated with transplant-free survival (HR 3.00, 95% CI 1.47–6.10, p=0.002) when adjusted for baseline forced vital capacity (FVC) and age. In patients with 12-month follow-up CT and lung function tests (n=89) an increase in 3% of WRVS (the minimal clinically important difference) was also significantly associated with reduced survival independent of FVC, and outperformed visual evaluation of progressive fibrosis. Conclusions WRVS is an automated CT biomarker which can identify patients with IPF at increased risk of progression and is able to reliably capture disease progression over time. © The authors 2024. |
publisher |
European Respiratory Society |
issn |
23120541 |
language |
English |
format |
Article |
accesstype |
All Open Access; Gold Open Access; Green Open Access |
record_format |
scopus |
collection |
Scopus |
_version_ |
1820775431554465792 |